Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarechale Cap. Regulatory News (MAC)

Share Price Information for Marechale Cap. (MAC)

Share Price is delayed by 15 minutes
Get Live Data
7.00    0.45 (6.87%)
Bid:
6.50
Ask:
7.50
Spread: 1.00 (15.385%)
Market Cap: £8.36m
MAC Live PriceLast checked at - London Stock Exchange

Intraday Marechale Cap. Share Chart

Half-year Report

19 Jan 2026 12:15

Marechale Capital Plc - Half-year Report

Marechale Capital Plc - Half-year Report

PR Newswire

LONDON, United Kingdom, January 19

19 January 2026

Marechale Capital plc

("Marechale Capital", “Marechale” or the "Company")

Half-yearly Results

Marechale Capital plc, an established City of London based corporate finance house with a long-term track record and a strong reputation for advising and financing high growth consumer brands, leisure, clean energy, mineral extraction and technology companies, announces its unaudited half-yearly results for the six months ended 31 October 2025 (the “Period”).

Chairman’s Statement

A difficult first half to the Company’s year has been a feature of recent years, with 2025 being no exception, particularly with the SME market being challenging. However, the market started to pick up in November 2025, and there has been a healthy new business pipeline developing in recent months.

During the six months ended 31 October 2025, the Company generated a gross profit of £55,310 (2024: £103,468) and delivered an operating loss of £177,066 (2024: loss of £138,485 ), resulting in an overall loss before tax of £176,515 (2024: loss of £178,261).

The Company’s balance sheet shows a net asset value of £3,063,198 (2024: £3,183,537), representing 2.56p (2024: 3.01p) of value per share in issue. The Board remains positive about the investments that it holds in its client companies, and in particular its core investment in Weardale Lithium.

Whilst there have been delays in completing some advisory projects during the Period, on a positive note, Marechale has in the last few months completed both debt and equity growth round transactions for Wright Brothers, the UK’s leading premium fish wholesaler and restaurant operator, KBH, one of the UK’s leading ‘out of home’ media companies on the UK’s railways and cinemas, Weardale Lithium, which has received planning for the UK’s first Direct Lithium Extraction plant and Chestnut Inns, one of the UK’s leading premium inn operators.

Cash at bank as at 31 October 2025 was £228,593 (2024: £223,700). However, in the months since the end of the Period, and based on the recent transactions that Marechale has completed, the Company has grown its cash at bank to £312,000 as at 14 January 2026.

The Board is working on a number of initiatives to create further value for shareholders over and above its core investment portfolio and corporate finance projects, including working with various potential businesses and individuals.

This plan to continue to develop Marechale’s strategic partnerships in order to enhance shareholder value, and develop new funding partners alongside its traditional investor relationships, has culminated in the successful completion of a placing in Marechale shares in October (as previously announced); this brought in two new strategic investors as well, in addition to all the Company’s directors investing too.

Marechale Capital continues to see interesting corporate finance and advisory projects; the Board believes despite the challenges of the last few years, that the SME market is looking more positive, and that there is a recognition of value in UK growth companies, particularly with new initiatives for the AIM markets, the Enterprise Investment Scheme (EIS), and the move to encourage more private and institutional funding into smaller UK companies.

Whilst the current economic climate is difficult, Marechale Capital remains diligent and is convinced that there will continue to be good advisory and investment opportunities in its core hospitality, renewable, clean energy and technology sectors over the short to medium term, where the Company can generate more value enhancing warrant and founding equity holdings alongside advisory cash fees. The Board is also hoping to agree terms on further strategic partnerships, and is in a number of advanced conversations with different parties.

Mark Warde-Norbury

Chairman

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

For further information please contact:

Marechale Capital

Mark Warde-Norbury / Patrick Booth-Clibborn

Tel: +44 (0)20 7628 5582

Cairn Financial Advisers LLP

Jo Turner / Sandy Jamieson

Tel: +44 (0)20 7213 0880

Income Statement (unaudited)
6 months ended 31 October 2025 2024
£ £
Revenue 111,932 148,500
Cost of sales (56,622) (45,032)
Gross profit 55,310 103,468
Administrative expenses (232,376) (241,953)
Operating loss (177,066) (138,485)
Exceptional credit 600 10,316
Loss on disposal of investments - (49,837)
Interest paid (49) (255)
(Loss) before tax (176,515) (178,261)
Taxation - -
(Loss) after tax (176,515) (178,261)
(Loss) per share
(Pence) (Pence)
- Basic (0.17) (0.17)
- Diluted (0.17) (0.17)

Balance Sheet (unaudited)
As at 31 October 31 October
2025 2024
Current assets
Available for sale investments 2,807,829 2,939,660
Trading investments 58,800 49,953
Trade and other receivables 91,172 52,856
Cash and cash equivalents 228,593 223,712
3,186,394 3,266,181
Current liabilities

Trade and other payables

PAYE

Bounce-back Loan

(110,811)

(4,885)

(7,500)

(54,338)

(10,806)

(10,000)

Total current liabilities (123,196) (75,144)
Net current assets 3,063,198 3,191,037
Bounce-back Loan – long-term - (7,500)
Net assets 3,063,198 3,183,537
Equity
Capital and reserves attributable to equity shareholders

Share capital

Share premium

955,530

575,790

847,530

481,290

Reserve for own shares (50,254) (50,254)
Retained profits/ (losses) 1,403,817 1,739,397
Reserve for share based payments 178,315 165,574
3,063,198 3,183,537
Cash Flow Statement (unaudited)
6 months ended 31 October 31 October
2024
£
Net cash from operating activities
Loss after tax (176,515) (178,261)
Reverse exceptional credits (600) (10,316)
Loss of disposal of investments - 49,837

Provision for share based payments

Reverse interest paid

-

49

15,406

255

Operating cash flows before movements in working capital (177,066) (123,079)
Movement in working capital
Decrease/ (increase) in receivables 13,852 (7,950)
(Decrease)/ Increase in payables (17,795) 3,108
Net movement in working capital (3,942) (4,842)
Operating cash out-flow (181,009) (127,921)
Investment activities
Expenditure on available for sale investments - -
Proceeds from sale of investments and options - 108,692
Cash flow from investing activities - 108,692

Financing

Share Capital

Bounce-back Loan repayments

Interest paid

Net financing

202,500

(5,000)

(48)

197,452

-

(5,000)

(255)

(5,255)

Net Increase / (decrease) in cash and cash equivalents 16,443 (24,484)
Cash and cash equivalents at start of the period 212,150 248,196
Cash and cash equivalents at end of the period 228,593 223,712
Increase / (decrease) in cash and cash equivalents 16,443 (24,484)

This financial information has been prepared in accordance with IFRS and International Financial Reporting Interpretations Committee ('IFRIC') interpretations adopted by the European Union, and with those parts of the Companies Act 2006 applicable to companies reporting under IFRS, with the prior period being reported on the same basis.



Date   Source Headline
8th Jun 20267:00 amPRNFCA Approves Stanford Capital Partners Change in Control
3rd Jun 20267:00 amPRNPosting of Circular and Notice of General Meeting
10th Apr 20261:00 pmPRNWeardale Lithium Receives £700k Grant
19th Jan 202612:15 pmPRNHalf-year Report
14th Oct 20254:00 pmPRNResult of AGM
14th Oct 20257:00 amPRNSubscription, Directors' Dealings, Related Party Transaction and Issue of Equity
16th Sep 20259:30 amPRNNotice of AGM
22nd Aug 20257:00 amPRNFinal Results
13th May 20257:00 amPRNIssue of Options to PDMR
19th Mar 20257:00 amPRNMarechale Advises on the Sale of Randalls
5th Feb 20251:30 pmPRNWeardale Lithium Planning Permission Application Update
29th Jan 202511:37 amPRNShare Price Movement
19th Dec 20244:30 pmPRNHalf-year Report
15th Oct 20242:30 pmPRNResult of AGM
20th Sep 20247:00 amPRNNotice of AGM
20th Aug 20247:00 amPRNFinal Results
6th Aug 20247:00 amPRNAppointment of Director
5th Dec 20237:00 amPRNHalf-year Report
22nd Nov 20231:00 pmPRNDirectorate Change
13th Oct 20233:51 pmPRNResult of AGM
19th Sep 20233:40 pmPRNNotice of AGM and Posting of Accounts
22nd Aug 20237:00 amPRNFinancial Statements for the Year Ended 30 April 2023
3rd Aug 202312:00 pmPRNHolding(s) in Company
28th Jun 20237:00 amPRNSubscription and Issue of Equity
2nd Mar 20227:00 amPRNPlacing, Subscription and Issue of Equity
1st Dec 20217:00 amPRNHalf-year Report
14th Oct 20213:28 pmRNSResult of AGM
11th Oct 20213:08 pmPRNHolding(s) in Company
8th Oct 20213:29 pmPRNHolding(s) in Company
5th Oct 20217:00 amPRNSubscription and Issue of Equity
22nd Sep 20212:57 pmPRNNotice of AGM
8th Sep 202111:54 amPRNHolding(s) in Company
7th Sep 20212:11 pmPRNDirector/PDMR Shareholding
23rd Aug 20217:00 amRNSFinal Results
12th Mar 20219:32 amPRNHolding(s) in Company
5th Mar 20211:29 pmPRNHolding(s) in Company
5th Mar 20218:50 amPRNHolding(s) in Company
4th Mar 20213:24 pmPRNTrading Update
4th Mar 20219:19 amPRNHolding(s) in Company
23rd Feb 20215:00 pmPRNHolding(s) in Company
23rd Feb 20217:00 amPRNDirector/PDMR Shareholding
10th Feb 20212:27 pmPRNHolding(s) in Company
10th Feb 20217:00 amPRNHolding(s) in Company
4th Feb 20219:15 amPRNExercise of Options and Issue of Equity
3rd Feb 20217:00 amPRNStatement re Share Price Movement
2nd Feb 20216:20 pmPRNHolding(s) in Company
26th Jan 202111:47 amPRNPlacing, Subscription and Issue of Equity
11th Dec 202012:47 pmPRNGrant of Options to Directors
24th Nov 20207:00 amPRNHalf-year Report
26th Oct 20201:16 pmPRNResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.